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compared with those of manual cleaning and disinfection, which include chlo-
ride such as slightly acidic hypochlorous acid water or titanium dioxide. Of
them, Bio-Kil (Cargico Group, Taiwan) is a platform nanotechnology with con-
struction of quaternary ammonium compound to create a covalent or ionic
bond and embedded into the surfaces of environment, forming a durable
copolymer with a physical bactericidal property. A pilot study in intensive
care units had shown that the BIO-Kil treatment can inhibit the growth of bac-
teria and evidently suppress its colonization from 49.62 to 10.38 CFU/10 cm2.
Today we will present further study of its effectiveness on controlling the
colonization of MDROs in the hospital settings. Together with hand hygiene
campaign and other infection control bundles, there is a new horizon for us
to achieve the zero tolerance of HAIs in the 21st century.SP 20-3
PROACTIVE INFECTION CONTROL MEASURES TO PREVENT NOSOCOMIAL
TRANSMISSION OF VRE
Vincent C. C. Cheng a,b, S. C. Wong b, K. Y. Yuen b. aInfection Control Team,
Queen Mary Hospital, Hong Kong Special Administrative Region;
bDepartment of Microbiology, The University of Hong Kong, Hong Kong
Special Administrative Region
We adopted a multifaceted assertive proactive infection control approach
to minimize the nosocomial transmission and outbreak of VRE in a non-
endemic area. Active surveillance culture, extensive contact tracing and
single room isolation with contact precautions, together with other
infection control measures, such as directly observed hand hygiene in
conscious patients before receiving meals and medications, stringent hand
hygiene during patient care practices, and environmental cleanliness are
essential in limiting intra- and inter-hospital transmission. With the
implementation of these infection control measures, the incidence of
nosocomial acquisition of VRE had significantly decreased from 0.46 per
10,000 patient-days to 0.10 per 10,000 patient-days (p < 0.001 under
Poisson assumptions).
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ANTIBIOTIC STEWARDSHIP
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BENEFITS OF ANTIMICROBIAL STEWARDSHIP IN HOSPITALS: EVIDENCE
FROM A RECENT COCHRANE REVIEW
Ian M. Gould. Department of Medical Microbiology, Aberdeen Royal
Infirmary, Foresterhill, Aberdeen, Scotland AB25 2ZN, United Kingdom
Antibiotic stewardship has been around now for several decades but has
received renewed focus as a means of slowing the development of antibiotic
resistance (AR). Cochrane reviews include only papers of sufficiently robust
methodology and at the date of the last review (2006) there were less than
100 published scientific papers so classified on Antibiotic Stewardship. In
recent years a greater proportion of published papers have been included
but almost all are from USA and Europe. The majority use interrupted time
series analysis, with about a quarter being randomised controlled trials.
Currently a new review is updating the data basis and I will include data from
many of these papers in this talk.
Restrictive interventions such as order forms and expert approval have a
more immediate effect than persuasive (educational) interventions such as
audit and academic detailing but the effects of both are well maintained
over at least 2 years. Most are delivered by multidisciplinary teams, followed
by ID/micro and pharmacists.
There is robust evidence that effective stewardship, leading to major
reduction (34-42%) in the use of key agents such as quinolones and
cephalosporins can reduce Clostridium difficile infection, MRSA, VRE and
multi resistant Gram negatives by 24-68%. Lessons can be learnt from this
data for the control of carbapenemases. Also, improved quality of
use can reduce mortality from CAP. No associated increases in
mortality, length of stay or infection specific re-admission have been
documented.
In summary, antibiotic stewardship has a valuable role to play, alongside
hand hygiene and surveillance/cohorting/isolation/suppression/decoloniza-
tion in the control of Multi-Drug Resistant Organisms (MDROs).SP 21-2
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Purpose: The ability to scale up health programs after the pilot project or
seeding funds ended has gained interest from health professionals, policy
makers and funders. Lessons learned from the Antibiotics Smart Use (ASU)
program might be useful. ASU aims at reducing antibiotic use in upper respi-
ratory infection, acute diarrhea and simple wound. Phase I tests interven-
tions (2007-8). Phase II assesses scaling-up feasibility (2008-9). Phase III
scales up ASU toward sustainability to achieve new social norms (2010-pre-
sent). The study aims at investigating ASU diffusion, scaling-up measures
and factors contributing to ASU adoption and sustainability.
Methods: ASU diffusion and factors regarding ASU adoption was assessed by
a mailed, self-administered survey for all hospitals. Scaling-up measures and
factors contributing to ASU continuity were assessed using previous ASU
evaluation research and in-depth interviews of 50 key informants from 15
ASU settings. Data were collected during MayeOctober 2014.
Results: Of 625 hospitals (response rate 52%), 91% were aware of ASU and
72% implemented ASU. The ASU adoption rate was 3% in 2008 and increased
to 17%, 25% and 27% during 2010-2012. Scaling up started with a model devel-
opment and followed by horizontal and vertical scaling-up measures. Hori-
zontal measures included building decentralized networks to promote
local ownerships. Vertical measures focused on integrating ASU into national
policies. The pay-for-performance policy by the National Health Security Of-
fice in 2009 greatly induced scaling-up. Factors involving ASU adoption
included to solve irrational use of medicines, to do the right thing, and to
improve quality of care. ASU continuity required ASU prime mover(s), man-
agement in hospitals, and external factors especially national policies.
Conclusion: ASU scaling-up starts with a model development and follows by
horizontal and vertical scaling-up measures. Despite limited resources, ASU
continues scaling up but its sustainability remains challenging as it needs
strong, long-term support from relevant national policies.SP 21-3
HOSPITAL INITIATIVES
Ching-Tai Huang. LinKou Chang Gung Memorial Hospital, Taiwan
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AN INTERNATIONAL APPROACH TO ANTIMICROBIAL STEWARDSHIP:
EXAMPLE FROM VIETNAM
Heiman Wertheim, MD PhD. Oxford University Clinical Research Unit, Viet
Nam
Antimicrobial resistance is a major global health threat. In the European
Union an estimated 25,000 deaths occur annually secondary to multi-drug-
resistant infections. No reliable estimates for developing countries exist, but
figures are likely to be higher. Strategies to contain antimicrobial resistance
were comprehensively set forth by the World Health Organization (WHO) in
2001. However, implementation in low- and middle-income countries, where
the need for effective antimicrobials is greatest, has thus far proved
problematic [3],[4].
In Viet Nam, where resistance rates are among the highest in Asia, the
challenge is urgent and great. A large population, high infectious disease
burden, and unrestricted access to antimicrobials make Viet Nam a hotspot
for the emergence of drug resistance. Adequate legislation to tackle
antimicrobial resistance in Viet Nam already exists, but a lack of resources
prevents effective policy enforcement.
